Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 107; no. 3; pp. 740 - 743
Main Authors Albertsson-Lindblad, Alexandra, Palsdottir, Thorgerdur, Smedby, Karin E, Weibull, Caroline E, Glimelius, Ingrid, Jerkeman, Mats
Format Journal Article
LanguageEnglish
Published Italy Fondazione Ferrata Storti 01.03.2022
Ferrata Storti Foundation
Subjects
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bendamustine Hydrochloride - administration & dosage
Bendamustine Hydrochloride - therapeutic use
Cancer and Oncology
Cancer och onkologi
Clinical Medicine
Cyclophosphamide - administration & dosage
Doxorubicin - administration & dosage
Humans
Klinisk medicin
Letters to the Editor
Lymphoma, Mantle-Cell - diagnosis
Lymphoma, Mantle-Cell - drug therapy
Lymphoma, Mantle-Cell - epidemiology
Medical and Health Sciences
Medicin och hälsovetenskap
Prednisone - administration & dosage
Rituximab - administration & dosage
Sweden - epidemiology
Vincristine - administration & dosage
Sweden
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Disclosures: AAL received grant support from Janssen Pharmaceutical NV as part of a collaboration between Karolinska Institutet and Janssen Pharmaceutical NV; CW and TP are part of a research collaboration between Karolinska Institutet and Janssen Pharmaceutical NV for which Karolinska Institutet has received grant support; IG participated in educational seminars run by Janssen Pharmaceutical NV; KES received a research grant from Janssen, honoraria from Takeda and Celgene; MJ received research support from Janssen Pharmaceutica NV, Celgene, Abbvie, Gilead, Roche and Astra Zeneca and honoraria from Roche, Gilead, BMS, Astra Zeneca, Janssen Genmab and Incyte.
Contributions: AAL, TP, IG, CEW, KES, MJ designed the study; TP, CEW, IG, AAL prepared data; AAL, TP and CEW performed data analysis, tables and figures; AAL, TP, IG, CEW, KES, MJ participated in the analysis and interpretation of results; AAL prepared the draft manuscript; AAL, TP, IG, CEW, KES, MJ critically reviewed the manuscript prior to submission.
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2021.279037